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Abstract
In the past 15 years, multiple clinical studies have identified a temporal association between red 
blood cell (RBC) transfusions and necrotizing enterocolitis (NEC). With some variability, most of 
these studies indicate that up to one-third of all cases of NEC involving very-low-birth weight 
infants may occur within 24–48 hours after receiving a RBC transfusion. There is also evidence 
that the risk of such transfusion-associated NEC may be higher in infants transfused with the 
greatest severity of anemia. In this article, we summarize the clinical evidence pertaining to these 
issues; specifically, the contribution of RBC transfusions, and the contribution of severity of 
underlying anemia, to the pathogenesis of a type of NEC potentially termed, “Transfusion/
Anemia-associated NEC”.
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Necrotizing enterocolitis is a leading cause of death among extremely premature infants with 
case-fatality rates of 20–30%.1 These infants also are a heavily-transfused population, and in 
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recent years, there has been renewed interest in potential adverse events following the 
administration of blood products, particularly in the context of the reported association 
between RBC transfusions and necrotizing enterocolitis (NEC).2, 3 In the last 15 years, 
several case reports and retrospective studies show that up to one-third of all VLBW infants 
who develop NEC may have received one or more RBC transfusions in the 24–72 hours 
prior to onset of NEC.4–26 However, two prospective studies12, 27 have not shown such an 
association between RBC transfusion and NEC; one of these two studies highlighted that it 
may be the severity of the underlying anemia, not the transfusion event, that may increase 
the risk of NEC.12 In the following sections, we review current evidence and the biological 
plausibility of these associations. A literature search was performed using the databases 
PubMed, EMBASE, and Scopus. To avoid bias in identification of existing studies, key 
words were carefully short-listed prior to the actual search from anecdotal experience and 
from PubMed’s Medical Subject Heading (MeSH) thesaurus.
The association between RBC transfusions and NEC in premature infants
There is increasing evidence to support this association, although the issue of causality 
remains unresolved. McGrady et al.28 were the first to notice the temporal association 
between RBC transfusions and NEC. They investigated an outbreak of 33 cases of NEC in 
their neonatal intensive care unit (NICU) in 1987 and found increased risk of NEC following 
transfusions [odds ratio (OR) 15.1, 95% confidence interval (CI) 2.59–92.51]. In subsequent 
years, this temporal association was noted again in a few case reports.29, 30 Bednarek et al.31 
also found some supportive evidence; while comparing transfusion practices in 6 NICUs, 
they noted that NICUs with fewer transfusions had a lower incidence of NEC (OR 0.3, CI 
0.1–0.8) than the NICUs that transfused premature infants more frequently (OR 1.1, CI 0.5–
2.2).
In recent years, the association between RBC transfusions and NEC has received significant 
investigative attention. Since 2006, several retrospective studies5, 11, 13–16, 21, 23, 25, 26, 32–38 
have consistently found this association with several common findings: (a) 25–40% of all 
cases developed NEC 2–48 hours after having received a RBC transfusion;
5, 11, 13, 21, 23, 25, 26, 28, 31, 33–38 (b) neonates with transfusion-associated NEC were more 
premature and had a lower birth weight than those who develop NEC unrelated to 
transfusion;5, 11, 13, 21, 23, 25, 26, 28, 31, 33–38 (c) transfusion-associated NEC has a delayed 
onset, usually beyond 4 weeks of postnatal age;5, 13, 21, 23, 25, 26, 28, 31, 33–38 (d) neonates 
with transfusion-associated NEC may have had one or more previous RBC transfusions;5, 25 
and (e) the risk of NEC may have been higher in infants who were severely anemic before 
the transfusion.21 Most of these studies did not find an effect of the storage age of RBCs.
5, 13, 25 There was conflicting evidence on the severity of illness in infants who developed 
NEC following RBC transfusions; Mally23 reported NEC in relatively-well, convalescing 
infants, whereas others found higher risk of transfusion-associated NEC in infants who had a 
patent ductus arteriosus (OR 2.68, CI 1.81–3.97)6, 13, 23, 26, 33, 37 and/or were on respiratory 
support at NEC onset (OR 3.16, CI 1.60–6.22).6, 11, 13, 23, 26, 33
Three studies have reported findings conflicting with the aforementioned studies. Harsono et 
al.39 found that RBC transfusions were actually protective against NEC. In a retrospective 
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review of the medical records of 2123 infants, they asked whether VLBW infants who 
receive RBC transfusions beyond ≥28 days were at increased risk of NEC in a 48-hour 
period following the transfusion. In their cohort, 43 (2%) infants developed NEC, and 26 of 
these 43 infants (60%) developed NEC within 48 hours after a transfusion. After controlling 
for birth weight, gender, and a history of umbilical artery catheter insertion, they found that 
RBC transfusions had a protective effect against NEC (OR= 0.30; 95% CI: 0.15–0.60). The 
authors posited that this protective effect of RBC transfusions may be mediated through the 
correction of tissue hypoxia related to chronic anemia. In a prospective case-control study, 
Sharma et al.27 compared 42 NEC cases with matched, equally-transfused controls and did 
not find an association of transfusion with NEC in either a 48-hour or 7-day time period 
before the onset of NEC. In a recent, prospective study, Patel et al.12 analyzed a multicenter 
cohort of 598 VLBW infants. They evaluated exposure to RBC transfusion in a given week 
and found no association between RBC transfusion and the subsequent development of NEC 
(adjusted cause-specific hazard ratio 0.44, 95% CI: 0.17–1.12). In contrast, the study 
reported that severe anemia (defined as a hemoglobin ≤ 8 g/dL) in a given week was 
associated with a higher risk of NEC (adjusted cause-specific hazard ratio 5.99, 95% CI 
2.00–18.0).
Mohamed and Shah6 performed meta-analysis of observational data from studies on 
transfusion-associated NEC and found increased odds of NEC within 48 hours after 
receiving a RBC transfusion. Meta-analysis of 5 studies5, 11, 21, 25, 32 showed increased odds 
of NEC after recent transfusion (OR 3.91, CI: 2.97–5.14). Meta-analysis of 4 of these 
studies25, 37–39 that reported adjusted estimates revealed a similar but lower risk of NEC 
(pooled adjusted OR 2.01, CI: 1.61–2.50). A more recent meta-analysis of 13 studies found 
no association between RBC transfusion and NEC occurring within 48 hours of transfusion 
(OR 1.13, 95% CI: 0.99–1.29) with high statistical heterogeneity among studies (I2=93%).40 
The differences between these two meta-analyses may be due to a positive-result or 
publication bias, with earlier studies all reporting an association between RBC transfusion 
and NEC vs. the lack of such an association in the more recent ones. In addition, a meta-
analysis of randomized trials comparing restrictive vs. liberal RBC transfusion strategies in 
preterm infants found no effect of more RBC transfusions (higher hemoglobin transfusion 
thresholds), compared to fewer RBC transfusions, on the risk of NEC (OR 0.6, CI 0.3–1.21).
40 The pooled point-estimate of effect from these randomized trials are similar to the point-
estimates of studies by Patel et al.12 and Sharma et al.,27 with each study favoring a lower 
risk of NEC associated with exposure to RBC transfusion.
Effects of RBC transfusions and anemia on gut perfusion and injury
In premature infants, both anemia and RBC transfusions can theoretically alter intestinal 
perfusion and cause/augment injury. Plausible mechanisms include immaturity of the 
splanchnic vascular bed, re-oxygenation injury in the anemic gut, and immune mechanisms 
similar to those seen in transfusion-related lung injury (TRALI). Current clinical evidence 
does not support a major contribution of the storage age of transfused RBCs to NEC,5, 13, 25 
but older RBCs could accentuate microvascular ischemia and tissue hypoxia.
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Host immaturity
The immaturity of the vascular autoregulatory responses in the neonatal gastrointestinal tract 
is well-known, and could potentially place the infant at increased risk of gut mucosal injury. 
Szabo et al.41 showed that hypoxia impaired the normal post-prandial hyperemic response 
and decreased the gut oxygen delivery in newborn piglets. Krimmel and coworkers42 
showed that RBC transfusions can dampen the normal postprandial increase in mesenteric 
blood flow in premature infants with a birth weight <1250 grams. In another study, Gupta et 
al.43 demonstrated that RBC transfusions reduced the mesenteric arterial blood flow in 
infants with a patent ductus arteriosus 4 hours after the transfusion. Blau et al.26 suggest that 
NEC may peak at the post-menstrual age of 31–32 weeks44, 45 because of a developmental 
susceptibility to neovascularization and oxygen toxicity during this period, possibly related 
to increased expression of angiogenic factors in the anemic gastrointestinal tract.46
Anemia
Anemia can impair splanchnic perfusion,41 resulting in tissue hypoxia, anaerobic 
metabolism, and accumulation of its by-products such as lactic acid.47 Anemia can also 
impair the normal maturation of vascular autoregulation in the premature intestine,48 
predisposing to ischemic injury, and possibly, NEC.47
Singh et al.21 reviewed the medical records of 111 preterm infants with confirmed NEC and 
222 matched controls, and found lower hematocrit to be associated with NEC (OR 1.10, 
p=0.01) in multivariate models. They showed that RBC transfusions within the preceding 24 
hours (OR 7.6, p=0.001) and 48 hours (OR 5.55, p=0.001) were associated with NEC. 
However, other retrospective studies led by Josephson,13 Christensen,5 Paul,25 and Blau26 
did not find a significant effect of anemia.
In convalescing preterm infants, anemia is a frequent, near-universal event. The most 
common reason for low hematocrits in this subgroup is anemia of prematurity. However, in 
infants with NEC, other etiologies may need to be carefully excluded. Some studies have 
shown an association of NEC with activation of the Thomsen-Friedenreich cryptic T antigen 
(T-antigen activation) on RBCs, causing low-grade hemolysis and anemia in multi-
transfused patients who have previously received blood from adult donors carrying anti-T 
antibodies.49 Although the pathophysiological significance of T-activation in NEC remains 
unresolved,50 the presence of low-grade, smoldering intestinal inflammation prior to 
transfusion may be difficult to exclude in some patients. This scenario may involve reverse 
causation with intestinal injury causing anemia and not otherwise. Growing preterm infants 
who are anemic but otherwise stable are usually monitored with an expectation of 
spontaneous improvement in hematocrits. Because anemia could manifest in premature 
infants with myriad presentations,51 non-specific symptoms of early NEC such as 
tachycardia, feeding intolerance, and irritability could be ascribed to anemia and treated with 
a transfusion. In these infants, later onset of NEC could be associated erroneously with the 
RBC transfusion.
In the study by Patel et al.,12 severe anemia in a given week was associated with a 6-fold 
higher risk of NEC. In additional analyses among RBC transfused infants, each 1 g/dL 
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decrease in the lowest measured hemoglobin in a given week was associated with a 65% 
increase in the risk of NEC (P<0.01). Between 49 to 90 days of age, infants with NEC, 
compared to those without NEC, tended to have a lower hemoglobin (mean difference: −1.5 
g/dL, p = 0.06). However, the study did not evaluate for the interaction between severe 
anemia and RBC transfusion, although several cases of NEC occurred following exposure to 
both within the same week. A recent case-crossover study by Le et al.52 found no 
association between RBC transfusion and NEC (OR 1.80, CI 0.60–5.37). A subgroup 
analysis reported that infants with anemia (Hb ≤9.3 g/dL) were at increased risk (OR for 
RBC transfusion and NEC = 6, CI 0.7–50) compared to those who were not anemic (OR = 
1, CI 0.2–5.0), although there was no statistical evidence of heterogeneity (test for subgroup 
difference p = 0.19).
Direct effects of RBC transfusions
Blau et al.26 hypothesized that transfusion-associated NEC may also share immunological 
mechanisms with TRALI. TRALI is speculated to result from a two-hit insult in which host 
neutrophils are primed by an antecedent illness, followed by passive transfusion of 
biological response mediators such as donor antibodies such as those directed against the 
human leukocyte antigens (HLA), biologically-active lipids, free hemoglobin, red cell 
membrane fragments, and inflammatory cytokines present in stored blood 53. Similar factors 
may cause mucosal injury in the premature intestine, which displays a developmentally-
regulated pro-inflammatory bias with exaggerated immune responses to bacterial and/or 
nutritional antigens.54, 55 Anti-HLA antibodies have been detected in some,56 but not all,26 
studies on premature infants who were transfused and developed NEC. Paul et al.25 reported 
that 83% donors in their cases of transfusion-associated NEC were male, who were less 
likely to carry anti-HLA antibodies in their blood than female donors. Another mechanistic 
consideration would invoke the presence of free hemoglobin and/or free heme (released 
from RBC lysis during storage and/or washing), interacting with additional humoral 
mediator(s) introduced via plasma.53 Ho et al.57 measured fecal calprotectin (FC) before and 
after RBC transfusions in VLBW infants, and showed that FC increased faster than baseline 
after RBC transfusions and were higher in multiple-transfused infants. In this cohort, FC 
was the highest in infants with the lowest hematocrits and in those who received RBCs that 
had been in storage for >21 days.
Stored blood
Stored RBCs show reduced deformability, increased aggregation, and the loss of nitric 
oxide. Nitric oxide stored in RBCs is covalently-bound to cysteine residues of hemoglobin 
and its gradual release helps maintain microvascular perfusion and tissue oxygen delivery. In 
stored blood, RBCs are rapidly depleted of nitric oxide, which correlates with loss of RBC 
function, and can be associated with a paradoxical reduction in oxygen delivery, 
vasoconstriction, and ischemic injury to the intestine (and other organs).58 Stored RBCs may 
also have direct pro-inflammatory effects such as activation of neutrophils to produce 
interleukin (IL)-8 and phospholipase A2. Transfused blood contains high levels of IL-1, IL-6 
and IL-8, which may rise further with increasing duration in storage.59
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Feeding and transfusion-related NEC
Three studies have addressed the issue of withholding feeds around the time of transfusion.
11, 32 After a cluster of cases of transfusion-associated NEC, Perciaccante et al.32 changed 
from a practice of no disruption of feeding schedules to a practice of withholding feedings 
from 4 hours before the start of the transfusion until 4 hours after the completion of the 
transfusion. Before introducing the practice of withholding feedings, they recorded a history 
of an RBC transfusion in the preceding 48 hours prior to onset of NEC in 7 out of 18 
(38.9%) cases of NEC. Following the change in feeding practices, they did not record any 
cases of NEC that occurred within 48 hours of a RBC transfusion. These findings are similar 
to those reported by El-Dib et al.,11 who also used a pre- vs. post-practice change design and 
detected a significant reduction in the incidence of transfusion-associated NEC from 5.3% to 
1.3% after instituting the feeding policy change. As part of a multicenter quality 
improvement (QI) initiative in 8 NICUs, Talavera et al.60 implemented withholding of 
feedings during transfusions (but not before or after) and allowed no changes in fortification 
or volume advancement on the day of transfusion coupled with standardized human-milk 
feeding. The study reported a decrease in NEC incidence from 8% to 3.1% (p = 0.001), with 
continued decline to 0.9% after additional interventions over a 3-year period as part of the 
QI effort. The observation that intestinal perfusion is increased by bolus feeding compared 
to continuous feeding or fasting suggests that any benefit from withholding feedings is 
multi-factorial.61, 62
Role of clinical initiatives to prevent anemia, such as delayed cord 
clamping
Potential means of preventing anemia, among premature neonates, include delayed clamping 
of the umbilical cord or the somewhat more rapid technique of cord stripping (also called 
cord milking), and methods for limiting phlebotomy losses. A Cochrane review of 15 
randomized controlled trials of delayed cord clamping or milking vs. immediate cord 
clamping, indicated that 38% fewer patients in the cord transfusion groups developed NEC 
(241 infants, RR 0.62, CI 0.43–0.9).63 Also, there were 39% fewer RBC transfusions among 
the cord transfusion recipients, but it was not possible to determine whether the lower NEC 
risk was due to fewer transfusions, or due to higher hematocrits (thus less anemia), or 
whether the lower risks of NEC and fewer transfusions were unrelated to each other.
Outcome of transfusion-associated vs. transfusion-independent NEC
Josephson et al.13 showed that infants with transfusion-associated NEC had a higher 
frequency of surgical intervention and longer duration of stay than those with non-
transfusion-associated NEC. The overall mortality in NEC/RBC-transfused and NEC/non-
RBC-transfused groups was similar (10/47, 21% vs. 7/46, 15%, respectively; p=0.45). These 
results contrast with the findings of Stritzke et al.,37 who reported mortality and morbidity 
data from 927 infants with NEC vs. 2781 VLBW controls from Canadian Neonatal 
Network. After adjusting for confounding factors, no significant differences in mortality/
neonatal morbidity were found between the two groups. Of all the studies on transfusion-
associated NEC, 6 reported unadjusted estimates of mortality.5, 11, 26, 32, 33, 37 In their meta-
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analysis, Mohamed and Shah6 detected increased mortality in patients who had transfusion-
associated NEC than those with NEC not associated with transfusion (pooled OR 1.88, CI 
1.35–2.61). None of the studies reported adjusted estimates.
Clinical outcomes in transfusion-associated NEC need careful evaluation because these 
infants are usually more premature and may have had a higher severity of illness prior to 
transfusion,5, 9, 11, 13, 21, 26, 32, 34, 35 both of which are independent predictors of morbidity 
and mortality in NEC.54 Josephson et al.13 reported that patients who developed NEC after 
receiving one or more transfusions also had a higher incidence of PDA and intraventricular 
hemorrhage, and more frequent use of central vascular catheters. In this particular study,13 
and in several others,11, 26, 33 infants who developed NEC after a transfusion were more 
likely to have been on respiratory support (supplemental oxygen/assisted ventilation) in the 
48 hour-period preceding the onset of NEC.
Conclusion
Based on current clinical evidence, “Transfusion/Anemia-associated NEC” appears to be a 
plausible clinical entity. However, there is a need for cautious interpretation of data because 
studies reporting these associations have been susceptible to bias and to the effect of 
confounding variables or reverse causation.64 There is a critical need for a developmentally-
relevant animal model to determine whether severe anemia or RBC transfusions could cause 
inflammatory injury in the premature intestine, or if injury results from an interplay between 
these risk factors. We also need large, prospective, multi-center trials to evaluate the effect of 
RBC transfusion and anemia on NEC and other outcomes, as well as the scientific merit of 
interventions such as withholding feedings before, during, and/or after RBC transfusion. 
Such large, multicenter trials are ongoing or planned (https://clinicaltrials.gov/ct2/show/
NCT01702805, http://neoepoch.com/wheat-trial/). In addition, clinical and pre-clinical 
studies to understand the potential interaction between anemia and RBC transfusion on the 
outcome of NEC are needed to provide a biologic basis for the reported epidemiologic 
associations. Strategies to decrease RBC transfusions, such as the use of recombinant 
erythropoietin or its synthetic, longer-acting homologues such as darbepoietin may also be 
relevant to these issues. Other potentially relevant approaches that require additional study 
include repletion of nitric oxide (NO) in stored RBCs before transfusion or administration of 
inhaled NO to at-risk neonates during transfusion.5
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